Principal Financial Group’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Principal Financial Group’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-43,457	Closed	-$491K	–	2534
2022 Q2	$491K	Sell	43,457 -295,462	-87%	-$3.54M	﹤0.01%	2065
2022 Q1	$5.5M	Sell	338,919 -323,615	-49%	-$8.29M	﹤0.01%	1632
2021 Q4	$31.4M	Sell	662,534 -186,423	-22%	-$11.2M	0.02%	646
2021 Q3	$61.5M	Buy	848,957 +84,594	+11%	+$6.12M	0.04%	356
2021 Q2	$64.2M	Buy	764,363 +477,321	+166%	+$31.5M	0.04%	364
2021 Q1	$13.9M	Buy	+287,042	New	+$15.6M	0.01%	1198

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Principal Financial Group's NBP Position: Q3 2022 in Review

Principal Financial Group sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2022, closing a stake of 43,457 shares — an estimated $491K sold.

Principal Financial Group first reported a position in NBP in Q1 2021 and held it in 6 quarters. The position peaked at $64.2M in Q2 2021. 75 funds tracked by Wall St. Rank hold NBP as of Q3 2022.

Principal Financial Group reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2022 after selling out during the quarter.
Principal Financial Group sold 43,457 NovaBridge Biosciences American Depositary Shares shares in Q3 2022, an estimated $491K.
Principal Financial Group first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2021 and held it in 6 quarters.
Principal Financial Group's NovaBridge Biosciences American Depositary Shares position peaked at $64.2M in Q2 2021.
75 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2022.

Based on Principal Financial Group's 13F filing for Q3 2022, filed 9 Nov 2022.